Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3K Buy
253
+114
+82% +$1.58K ﹤0.01% 1515
2026
Q2
$2K Hold
139
– – ﹤0.01% 1480
2026
Q1
$2K Sell
139
-7,790
-98% -$99.2K ﹤0.01% 1461
2025
Q4
$130K Buy
7,929
+1,041
+15% +$16.2K ﹤0.01% 806
2025
Q3
$92K Buy
6,888
+1,874
+37% +$22.2K ﹤0.01% 835
2025
Q2
$64K Buy
5,014
+1,515
+43% +$18.2K ﹤0.01% 822
2025
Q1
$36K Buy
+3,499
New +$45K ﹤0.01% 885

Other funds holding PATH

CX Institutional's PATH Position: Q3 2026 in Review

CX Institutional increased its UiPath (PATH) stake by 82% in Q3 2026, buying an estimated $1.58K and bringing the position to 253 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #1515.

CX Institutional first reported a position in PATH in Q1 2025 and has held it in 7 quarters since. The position peaked at $130K in Q4 2025. 21 funds tracked by Wall St. Rank hold PATH as of Q3 2026.

  • CX Institutional held 253 shares of UiPath worth $3K as of Q3 2026.
  • CX Institutional bought 114 UiPath shares in Q3 2026, an estimated $1.58K.
  • UiPath made up ﹤0.01% of CX Institutional's portfolio in Q3 2026, its #1515 holding.
  • CX Institutional first reported a position in UiPath in Q1 2025 and has held it in 7 quarters since.
  • CX Institutional's UiPath position peaked at $130K in Q4 2025.
  • 21 funds tracked by Wall St. Rank held UiPath as of Q3 2026.

Based on CX Institutional's 13F filing for Q3 2026, filed 2 Oct 2026.